The causes of antimicrobial resistance (AMR) in developing countries are complex and may
be rooted in practices of health care professionals and patients' behavior towards the use of …

Antimalarial drug toxicity is viewed differently depending upon whether the clinical indication
is for malaria treatment or prophylaxis. In the treatment of Plasmodium falciparum malaria …

Abstract Introduction The Global Action Plan (GAP) on antimicrobial resistance (AMR)
delivers a 'One Health'strategy for the development of the national action plan. It encourages …

Malaria is a great concern for global health and accounts for a large amount of morbidity and
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …

Background Increasing access to and targeting of artemisinin-based combination therapy
(ACT) is a key component of malaria control programmes. To maximize efficacy of ACT and …

Malaria is one of the major diseases in the world. Due to the rapid spread of parasite
resistance to available antimalarial drugs there is an urgent need for new antimalarials with …

Functional analysis of the Plasmodium falciparum genome is restricted because of the
limited ability to genetically manipulate this important human pathogen. We have developed …

Malaria is a global problem, and there is a critical need for further understanding of the
disease process. When malarial parasites invade and develop within the bloodstream, they …

The rapid increase in access to antiretroviral therapy in developing countries has brought
with it new challenges. These include the unprecedented need for lifelong treatment for an …

Background and objective: There are several reports of sub‐standard and counterfeit
antimalarial drugs circulating in the markets of developing countries; we aimed to review the …